Status:
COMPLETED
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Lead Sponsor:
Goethe University
Collaborating Sponsors:
Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research
Conditions:
Adult Acute Lymphocytic Leukemia
Eligibility:
All Genders
15-65 years
Phase:
PHASE4
Brief Summary
The study evaluates the efficacy and tolerability of an intensified induction and consolidation therapy. Thereafter patients receive individualised treatment stratified according to relapse risk with ...
Eligibility Criteria
Inclusion
- Acute lymphoblastic leukemia (pro-B, common, pre-B, early T, thymic T, mature T)
- Age 15-65 yrs (\*55-65 years if biologically younger according to general condition)
- Written informed consent
Exclusion
- Severe comorbidity or leukemia associated complications
- Late relapse of pediatric ALL or ALL as second malignancy
- Cytostatic pre-treatment
- Pregnancy
- Severe psychiatric illness or other circumstances which may compromise cooperation of the patient
- Participation in other clinical trials interfering with the study therapy
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2013
Estimated Enrollment :
1883 Patients enrolled
Trial Details
Trial ID
NCT00198991
Start Date
April 1 2003
End Date
June 30 2013
Last Update
August 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Frankfurt, Medical Dept. II
Frankfurt, Germany, 60590